Stay updated on PANDORE Clinical Trial: Pembrolizumab in Bladder Cancer

Sign up to get notified when there's something new on the PANDORE Clinical Trial: Pembrolizumab in Bladder Cancer page.
Latest website image capture
Clouds background image

Latest updates to the PANDORE Clinical Trial: Pembrolizumab in Bladder Cancer page

  1. Check
    4 days ago
    Change Detected
    Summary
    The clinical trial record for a Phase II study of neoadjuvant pembrolizumab in muscle-invasive bladder cancer is displayed, with details on eligibility, study design, treatment, and response measures.
    Difference
    41%
    Check dated 2026-11-09T12:58:44.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    The footer revision changes from v3.7.2 to v3.8.0, while the page continues to show a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-02T12:30:32.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    A sitewide notice announces NIH’s terminology transition from “Artificial Intelligence” to “Super Intelligence.” The study record itself remains unavailable behind a 403 error.
    Difference
    1%
    Check dated 2026-10-26T13:52:18.000Z thumbnail image
  4. Check
    25 days ago
    Change Detected
    Summary
    The footer now displays site revision v3.7.2 instead of v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-19T13:56:17.000Z thumbnail image
  5. Check
    32 days ago
    Change Detected
    Summary
    The footer revision identifier changed from v3.7.0 to v3.7.1 on the 403 Forbidden page.
    Difference
    0.2%
    Check dated 2026-10-12T14:36:45.000Z thumbnail image
  6. Check
    53 days ago
    Change Detected
    Summary
    The study page now displays a 403 error page instead of the study record details. This indicates the page is currently inaccessible.
    Difference
    17%
    Check dated 2026-09-21T21:00:12.000Z thumbnail image

Stay in the know with updates to PANDORE Clinical Trial: Pembrolizumab in Bladder Cancer

Enter your email address, and we'll notify you when there's something new on the PANDORE Clinical Trial: Pembrolizumab in Bladder Cancer page.